Concern Over St. Jude's Heart Device Sends Stock Plunging (STJ)

Concern Over St. Jude’s Heart Device Sends Stock Plunging (STJ)

RSS

Medical company, St. Jude Medical, Inc.(STJ) saw a sharp decline Tuesday, after concern with recent heart device product.

The company’s stock fell 12% after news that major flaws were found in their testing and oversight of a heart device, and how inspections are done on its products.

The FDA has been focusing on one of the company’s products called Durata, which is a electrial wite that connects an implanted defibrillator to a patients heart. In this product, the company uses a material called Optim, but now the FDA is questioning the company about the quality and effectiveness of the material used.

The company has been in the spotlight for a few months since the failure of a product called Riata. However, STJ is insisting that Durata is a safe product, going against FDA recommendation that patients wait until the product’s safety is further proven.

St. Jude shares were down $4.36, or -12.27% during Wednesday afternoon trading. The stock is down 8.6% YTD.

The Bottom Line
Shares of St.Jude Medical, Inc (STJ) have a 2.58% dividend yield, based on last night’s closing stock price of $35.71. The stock has technical support in the $27-$28 price area. If the shares can firm up, we see overhead resistance around the $36 price level.

St. Jude Medical, Inc.(STJ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.1 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today